<DOC>
	<DOCNO>NCT01196455</DOCNO>
	<brief_summary>This open-label , non-comparative efficacy safety study Capecitabine Mitomycin C first-line treatment patient previously untreated metastatic breast cancer .</brief_summary>
	<brief_title>Capecitabine Mitomycin C Treatment Patients With Metastatic Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<criteria>Histologically/cytologically confirm breast cancer Metastatic breast cancer , least one target lesion accord RECIST criterion . Bone metastases , leptomeningeal disease , ascites , pleural pericardial effusion , inflammatory breast disease , lymphangitic spread cystic lesion acceptable target lesion . Target lesion must ≥ 10 mm long diameter measure one dimension use spiral CT , ≥ 20 mm long diameter measure one dimension use conventional technique . In addition definition pertain target lesion ( ) RECIST criterion , target lesion ( ) must previously irradiate ( newly arise lesion previously irradiate area acceptable ) . Age &gt; 18 year Signed informed consent obtain prior initiation studyspecific procedure treatment Prior cytotoxic chemotherapy active/passive immunotherapy metastatic breast disease Prior usage capecitabine mitomycin adjuvant neoadjuvant treatment Life expectancy &lt; 3 month Notambulatory ECOG performance status &gt; 1 Insufficient hematological , renal hepatic function : hemoglobin &lt; 8.0 g/dL absolute neutrophil count ( ANC ) &lt; 1.5 x 109/L platelet count &lt; 100 x 109/L serum creatinine &gt; 1.25 x N* total bilirubin &gt; 2.0 x N* ASAT and/or ALAT &gt; 2.5 x N* ( case liver metastases &gt; 5 x N* ) alkaline phosphatase &gt; 2.5 x N* ( case liver metastases &gt; 5 x N* , case bone metastases &gt; 10 x N* ) *N = upper limit standard range Severe renal impairment [ creatinine clearance &lt; 30 mL/min ( calculate accord cockcroft Gault ) ]</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Metastatic breast cancer patient</keyword>
</DOC>